Food
Date | Broker name | New | Price | Old price target | New price target | Broker change |
---|---|---|---|---|---|---|
20-Jul-22 | Barclays | Overweight | 97.50 | 137.00 | 137.00 | Reiteration |
21-Apr-22 | Barclays | Overweight | 100.95 | 136.00 | 136.00 | Reiteration |
17-Feb-22 | Barclays | Overweight | 109.80 | 135.00 | 136.00 | Reiteration |
02-Aug-21 | Barclays | Overweight | 128.35 | 133.00 | 135.00 | Reiteration |
01-Jul-21 | Barclays | Overweight | 119.00 | 131.00 | 133.00 | Reiteration |
10-Aug-12 | AlphaValue | Sell | - | - | - | DownGrade |
24-Feb-12 | AlphaValue | Reduce | - | - | - | DownGrade |
08-Aug-11 | AlphaValue | Add | - | - | - | Upgrade |
05-Aug-11 | Royal Bank of Scotland | Buy | - | - | - | Reiteration |
27-Apr-11 | AlphaValue | Reduce | - | - | - | DownGrade |
11-Mar-11 | AlphaValue | Add | - | - | - | Upgrade |
04-Mar-11 | AlphaValue | Reduce | - | - | - | DownGrade |
14-Feb-11 | JP Morgan Cazenove | Overweight | - | - | - | New Coverage |
08-Dec-10 | Collins Stewart | Buy | - | - | - | New Coverage |
09-Nov-10 | Evolution Securities | Add | - | - | - | DownGrade |
02-Sep-10 | Goldman Sachs | Neutral | - | - | - | DownGrade |
06-Jul-10 | Evolution Securities | Buy | - | - | - | New Coverage |
24-Nov-09 | Goldman Sachs | Buy | - | - | - | Reiteration |
17-Nov-09 | Societe Generale | Buy | - | - | - | New Coverage |
30-Oct-09 | Goldman Sachs | Buy | - | - | - | Reiteration |
Currency | Euro |
Share Price | 79.40 |
Change Today | -0.30 |
% Change | -0.38 % |
52 Week High | 99.0 |
52 Week Low | 71.7 |
Volume | 69,687 |
Shares Issued | 173.60m |
Market Cap | 13,784m |
RiskGrade | 121 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 3 |
Buy | 4 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 0 |
Total | 13 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 11-Apr-24 | 12-Oct-23 |
Paid | 10-May-24 | 10-Nov-23 |
Amount | 80.80¢ | 34.60¢ |
Time | Volume / Share Price |
18:28 | 8 @ 79.45 |
18:11 | 2,593 @ 79.44 |
18:09 | 36,304 @ 79.40 |
18:04 | 120 @ 79.40 |
17:42 | 77 @ 79.53 |
Chair | Tom Moran |
CEO | Edmond Scanlon |
CFO | Marguerite Larkin |
You are here: research